These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 11745966)

  • 41. Biochemical and Functional Interplay Between Ion Channels and the Components of the Dystrophin-Associated Glycoprotein Complex.
    Leyva-Leyva M; Sandoval A; Felix R; González-Ramírez R
    J Membr Biol; 2018 Aug; 251(4):535-550. PubMed ID: 29779049
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Culture of human skeletal muscle myoblasts: timing appearance and localization of dystrophin-glycoprotein complex and vinculin-talin-integrin complex.
    Trimarchi F; Favaloro A; Fulle S; Magaudda L; Puglielli C; Di Mauro D
    Cells Tissues Organs; 2006; 183(2):87-98. PubMed ID: 17053325
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hyperthermic seizures and aberrant cellular homeostasis in Drosophila dystrophic muscles.
    Marrone AK; Kucherenko MM; Wiek R; Göpfert MC; Shcherbata HR
    Sci Rep; 2011; 1():47. PubMed ID: 22355566
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cellular and molecular properties of alpha-dystrobrevin in skeletal muscle.
    Enigk RE; Maimone MM
    Front Biosci; 2001 Jan; 6():D53-64. PubMed ID: 11145920
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of sarcoglycan complex on mechanical signal transduction in murine skeletal muscle.
    Barton ER
    Am J Physiol Cell Physiol; 2006 Feb; 290(2):C411-9. PubMed ID: 16162659
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic Engineering of Dystroglycan in Animal Models of Muscular Dystrophy.
    Sciandra F; Bigotti MG; Giardina B; Bozzi M; Brancaccio A
    Biomed Res Int; 2015; 2015():635792. PubMed ID: 26380289
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dissecting the signaling and mechanical functions of the dystrophin-glycoprotein complex.
    Judge LM; Haraguchiln M; Chamberlain JS
    J Cell Sci; 2006 Apr; 119(Pt 8):1537-46. PubMed ID: 16569668
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The molecular cross talk of the dystrophin-glycoprotein complex.
    Gawor M; Prószyński TJ
    Ann N Y Acad Sci; 2018 Jan; 1412(1):62-72. PubMed ID: 29068540
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intermediate filaments and the function of the dystrophin-protein complex.
    Blake DJ; Martin-Rendon E
    Trends Cardiovasc Med; 2002 Jul; 12(5):224-8. PubMed ID: 12161077
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The childhood muscular dystrophies: making order out of chaos.
    Tsao CY; Mendell JR
    Semin Neurol; 1999; 19(1):9-23. PubMed ID: 10711985
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Defects in neuromuscular junction structure in dystrophic muscle are corrected by expression of a NOS transgene in dystrophin-deficient muscles, but not in muscles lacking alpha- and beta1-syntrophins.
    Shiao T; Fond A; Deng B; Wehling-Henricks M; Adams ME; Froehner SC; Tidball JG
    Hum Mol Genet; 2004 Sep; 13(17):1873-84. PubMed ID: 15238508
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oxidative stress and the pathogenesis of muscular dystrophies.
    Rando TA
    Am J Phys Med Rehabil; 2002 Nov; 81(11 Suppl):S175-86. PubMed ID: 12409822
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Disrupted mechanical stability of the dystrophin-glycoprotein complex causes severe muscular dystrophy in sarcospan transgenic mice.
    Peter AK; Miller G; Crosbie RH
    J Cell Sci; 2007 Mar; 120(Pt 6):996-1008. PubMed ID: 17311848
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Secondary reduction of alpha7B integrin in laminin alpha2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle.
    Cohn RD; Mayer U; Saher G; Herrmann R; van der Flier A; Sonnenberg A; Sorokin L; Voit T
    J Neurol Sci; 1999 Mar; 163(2):140-52. PubMed ID: 10371075
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Zeta-sarcoglycan, a novel component of the sarcoglycan complex, is reduced in muscular dystrophy.
    Wheeler MT; Zarnegar S; McNally EM
    Hum Mol Genet; 2002 Sep; 11(18):2147-54. PubMed ID: 12189167
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular basis of muscular dystrophies.
    Cohn RD; Campbell KP
    Muscle Nerve; 2000 Oct; 23(10):1456-71. PubMed ID: 11003781
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The neurobiology of the dystrophin-associated glycoprotein complex.
    Waite A; Tinsley CL; Locke M; Blake DJ
    Ann Med; 2009; 41(5):344-59. PubMed ID: 19172427
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of aquaporin-4 in muscle and muscular dystrophy.
    Crosbie RH; Dovico SA; Flanagan JD; Chamberlain JS; Ownby CL; Campbell KP
    FASEB J; 2002 Jul; 16(9):943-9. PubMed ID: 12087055
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Caveolin-3 is not an integral component of the dystrophin glycoprotein complex.
    Crosbie RH; Yamada H; Venzke DP; Lisanti MP; Campbell KP
    FEBS Lett; 1998 May; 427(2):279-82. PubMed ID: 9607328
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dystrophinopathies and related disorders.
    Cherin P
    Curr Opin Rheumatol; 1995 Nov; 7(6):475-85. PubMed ID: 8579967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.